A detailed history of Allen Capital Group, LLC transactions in Organon & Co. stock. As of the latest transaction made, Allen Capital Group, LLC holds 13,660 shares of OGN stock, worth $102,859. This represents 0.01% of its overall portfolio holdings.

Number of Shares
13,660
Holding current value
$102,859
% of portfolio
0.01%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Oct 27, 2025

BUY
$8.4 - $10.85 $114,744 - $148,211
13,660 New
13,660 $145,000
Q4 2024

Jan 23, 2025

BUY
$14.44 - $18.83 $145,223 - $189,373
10,057 New
10,057 $150,000

Others Institutions Holding OGN

About Organon & Co.


  • Ticker OGN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 254,330,000
  • Market Cap $1.92B
  • Description
  • Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...
More about OGN
Track This Portfolio

Track Allen Capital Group, LLC Portfolio

Follow Allen Capital Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Allen Capital Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Allen Capital Group, LLC with notifications on news.